This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1993 Apr;25(2 Suppl 1):21-4.

Cardiopulmonary effects of OKT3: determinants of hypotension, pulmonary edema, and cardiac dysfunction

M R Costanzo-Nordin¹

Affiliations

PMID: 8465416

Review

Cardiopulmonary effects of OKT3: determinants of hypotension, pulmonary edema, and cardiac dysfunction

M R Costanzo-Nordin. Transplant Proc. 1993 Apr.

. 1993 Apr;25(2 Suppl 1):21-4.

Author

M R Costanzo-Nordin¹

Affiliation

¹ Department of Medicine, Loyola University Chicago, Maywood, IL 60153.

PMID: 8465416

No abstract available

PubMed Disclaimer

Similar articles

Muromonab CD3 (Orthoclone OKT3).
Takahashi K. Takahashi K. J Toxicol Sci. 1995 Sep;20(4):483-4. J Toxicol Sci. 1995. PMID: 8531248 No abstract available.
Increased risk of pulmonary edema in diabetic patients undergoing preemptive pancreas transplantation with OKT3 induction.
Sindhi R, Stratta RJ, Taylor RJ, Lowell JA, Sudan D, Castaldo P, Bynon JS, Pillen TJ. Sindhi R, et al. Transplant Proc. 1995 Dec;27(6):3016-7. Transplant Proc. 1995. PMID: 8539819 Clinical Trial. No abstract available.
Anaesthesia of the spinal cord-injured patient: cardiovascular problems and their management.
Troll GF, Dohrmann GJ. Troll GF, et al. Paraplegia. 1975 Nov;13(3):162-71. doi: 10.1038/sc.1975.27. Paraplegia. 1975. PMID: 1208115
OKT3-induced cytokine-release syndrome: renal effects (cytokine nephropathy).
First MR, Schroeder TJ, Hariharan S. First MR, et al. Transplant Proc. 1993 Apr;25(2 Suppl 1):25-6. Transplant Proc. 1993. PMID: 8465417 Review. No abstract available.
General aspects of cytokine-release syndrome: timing and incidence of symptoms.
Jeyarajah DR, Thistlethwaite JR Jr. Jeyarajah DR, et al. Transplant Proc. 1993 Apr;25(2 Suppl 1):16-20. Transplant Proc. 1993. PMID: 8465415 Review.

See all similar articles

Cited by

New immunosuppressive drugs in heart transplantation.
Costanzo MR. Costanzo MR. Curr Control Trials Cardiovasc Med. 2001;2(1):45-53. doi: 10.1186/cvm-2-1-045. Curr Control Trials Cardiovasc Med. 2001. PMID: 11806772 Free PMC article.
Muromonab CD3: a reappraisal of its pharmacology and use as prophylaxis of solid organ transplant rejection.
Wilde MI, Goa KL. Wilde MI, et al. Drugs. 1996 May;51(5):865-94. doi: 10.2165/00003495-199651050-00010. Drugs. 1996. PMID: 8861551 Review.
Selective, efficient modulation of activated CD4+ αβT cells by the novel humanized antibody GZ-αβTCR targeting human αβTCR.
Blank G, Welker C, Haarer J, Sterk M, Nadalin S, Yañez VA, Joos TO, Menrad A, Snell D, LaCorcia G, Königsrainer A, Handgretinger R, Schilbach K. Blank G, et al. Bone Marrow Transplant. 2015 Mar;50(3):390-401. doi: 10.1038/bmt.2014.263. Epub 2014 Nov 17. Bone Marrow Transplant. 2015. PMID: 25402416
Acute lung injury during antithymocyte globulin therapy for aplastic anemia.
Goligher EC, Cserti-Gazdewich C, Balter M, Gupta V, Brandwein JE. Goligher EC, et al. Can Respir J. 2009 Mar-Apr;16(2):e3-5. doi: 10.1155/2009/190313. Can Respir J. 2009. PMID: 19399304 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Medical
- MedlinePlus Health Information